{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:15:14Z","timestamp":1775888114692,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["EY007892"],"award-info":[{"award-number":["EY007892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 EY08126"],"award-info":[{"award-number":["P30 EY08126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 ES000267"],"award-info":[{"award-number":["P30 ES000267"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research to Prevent Blindness, Inc"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ajo.2011.08.033","type":"journal-article","created":{"date-parts":[[2011,10,31]],"date-time":"2011-10-31T07:57:28Z","timestamp":1320047848000},"page":"460-467.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Plasma Biomarkers of Oxidative Stress and Genetic Variants in Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"153","author":[{"suffix":"Jr","given":"Milam A.","family":"Brantley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa P.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barton J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasra A.","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Paul","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2011.08.033_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.1941.00870100042005","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2011.08.033_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"18","key":"10.1016\/j.ajo.2011.08.033_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.1994.03520180037032","article-title":"Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration","volume":"272","author":"Seddon","year":"1994","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ajo.2011.08.033_bib5","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1001\/jama.294.24.3101","article-title":"Dietary intake of antioxidants and risk of age-related macular degeneration","volume":"294","author":"van Leeuwen","year":"2005","journal-title":"JAMA"},{"issue":"43","key":"10.1016\/j.ajo.2011.08.033_bib6","doi-asserted-by":"crossref","first-page":"42027","DOI":"10.1074\/jbc.M305460200","article-title":"Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration","volume":"278","author":"Gu","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ajo.2011.08.033_bib7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1074\/mcp.M800453-MCP200","article-title":"Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers","volume":"8","author":"Gu","year":"2009","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajo.2006.08.032","article-title":"Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study","volume":"143","author":"Rochtchina","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2011.08.033_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajo.2005.07.059","article-title":"Evaluation of plasma homocysteine and risk of age-related macular degeneration","volume":"141","author":"Seddon","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2011.08.033_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0891-5849(02)01040-7","article-title":"Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses","volume":"33","author":"Jones","year":"2002","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.ajo.2011.08.033_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.freeradbiomed.2003.09.006","article-title":"Oxidation of glutathione and cysteine in human plasma associated with smoking","volume":"35","author":"Moriarty","year":"2003","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.ajo.2011.08.033_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1515\/CCLM.2004.088","article-title":"Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia","volume":"42","author":"Bicikova","year":"2004","journal-title":"Clin Chem Lab Med"},{"issue":"11\u201312","key":"10.1016\/j.ajo.2011.08.033_bib13","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1089\/ars.2006.8.1975","article-title":"Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease","volume":"8","author":"Calabrese","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"10.1016\/j.ajo.2011.08.033_bib14","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1152\/jappl.1993.75.6.2419","article-title":"Systemic deficiency of glutathione in cystic fibrosis","volume":"75","author":"Roum","year":"1993","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.ajo.2011.08.033_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0891-5849(97)00286-4","article-title":"Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes","volume":"24","author":"Samiec","year":"1998","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.ajo.2011.08.033_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc10-1006","article-title":"Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine","volume":"34","author":"Sekhar","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0021-9150(99)00418-9","article-title":"Redox status of plasma homocysteine and other plasma thiols in stroke patients","volume":"151","author":"Andersson","year":"2000","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ajo.2011.08.033_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.freeradbiomed.2010.11.029","article-title":"Cysteine\/cystine redox signaling in cardiovascular disease","volume":"50","author":"Go","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"18","key":"10.1016\/j.ajo.2011.08.033_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199505043321804","article-title":"Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers","volume":"332","author":"Morrow","year":"1995","journal-title":"N Engl J Med"},{"issue":"12 Pt 2","key":"10.1016\/j.ajo.2011.08.033_bib20","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1164\/rccm.2206011","article-title":"The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease","volume":"166","author":"Morrow","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ajo.2011.08.033_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.freeradbiomed.2010.11.023","article-title":"F2-isoprostanes as an indicator and risk factor for coronary heart disease","volume":"50","author":"Davies","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1750-3639.2005.tb00511.x","article-title":"The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation","volume":"15","author":"Roberts","year":"2005","journal-title":"Brain Pathol"},{"issue":"1\u20132","key":"10.1016\/j.ajo.2011.08.033_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1089\/ars.2005.7.202","article-title":"Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension","volume":"7","author":"Fessel","year":"2005","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.ajo.2011.08.033_bib24","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1542\/peds.2009-0434","article-title":"Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease","volume":"124","author":"Vento","year":"2009","journal-title":"Pediatrics"},{"issue":"5720","key":"10.1016\/j.ajo.2011.08.033_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.ajo.2011.08.033_bib26","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5720","key":"10.1016\/j.ajo.2011.08.033_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"issue":"5720","key":"10.1016\/j.ajo.2011.08.033_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajo.2011.08.033_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/444437","article-title":"Susceptibility genes for age-related maculopathy on chromosome 10q26","volume":"77","author":"Jakobsdottir","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"21","key":"10.1016\/j.ajo.2011.08.033_bib30","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddi353","article-title":"Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk","volume":"14","author":"Rivera","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"5801","key":"10.1016\/j.ajo.2011.08.033_bib31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"issue":"5801","key":"10.1016\/j.ajo.2011.08.033_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration","volume":"314","author":"Dewan","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajo.2011.08.033_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ajo.2011.08.033_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajo.2011.08.033_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ejhg.2008.140","article-title":"Variation near complement factor I is associated with risk of advanced AMD","volume":"17","author":"Fagerness","year":"2009","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.ajo.2011.08.033_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ejhg.2009.113","article-title":"Support for the involvement of complement factor I in age-related macular degeneration","volume":"18","author":"Ennis","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.ajo.2011.08.033_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/07853890601097030","article-title":"Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications","volume":"38","author":"Hageman","year":"2006","journal-title":"Ann Med"},{"issue":"10","key":"10.1016\/j.ajo.2011.08.033_bib38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng1890","article-title":"A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration","volume":"38","author":"Hughes","year":"2006","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-008-0112-9","article-title":"Immunopathological aspects of age-related macular degeneration","volume":"30","author":"Patel","year":"2008","journal-title":"Semin Immunopathol"},{"issue":"25","key":"10.1016\/j.ajo.2011.08.033_bib40","doi-asserted-by":"crossref","first-page":"16939","DOI":"10.1074\/jbc.M808166200","article-title":"Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury","volume":"284","author":"Thurman","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ajo.2011.08.033_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.exer.2006.11.015","article-title":"Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments","volume":"84","author":"Chen","year":"2007","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm1709","article-title":"Oxidative damage-induced inflammation initiates age-related macular degeneration","volume":"14","author":"Hollyfield","year":"2008","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ajo.2011.08.033_bib43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0009-8981(98)00089-8","article-title":"Glutathione measurement in human plasma","volume":"275","author":"Jones","year":"1998","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajo.2011.08.033_bib45","first-page":"3003","article-title":"Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress","author":"Morrow","year":"1999","journal-title":"Methods Enzymol"},{"issue":"3\u20134","key":"10.1016\/j.ajo.2011.08.033_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0891-5849(91)90076-F","article-title":"Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress","volume":"10","author":"Morrow","year":"1991","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.ajo.2011.08.033_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nprot.2006.375","article-title":"Quantification of F2-isoprostanes as a biomarker of oxidative stress","volume":"2","author":"Milne","year":"2007","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/338688","article-title":"Score tests for association between traits and haplotypes when linkage phase is ambiguous","volume":"70","author":"Schaid","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ajo.2011.08.033_bib49","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1167\/iovs.04-0949","article-title":"Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state","volume":"46","author":"Jiang","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2011.08.033_bib50","first-page":"121536","article-title":"Association of complement factor H polymorphisms with exudative age-related macular degeneration","author":"Chen","year":"2006","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.ajo.2011.08.033_bib51","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1167\/iovs.07-0860","article-title":"Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy","volume":"49","author":"Lee","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2011.08.033_bib52","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1167\/iovs.07-1517","article-title":"Multiple gene polymorphisms in the complement factor h gene are associated with exudative age-related macular degeneration in chinese","volume":"49","author":"Ng","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2011.08.033_bib53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neulet.2010.11.048","article-title":"Correlation of complement factor H gene polymorphisms with exudative age-related macular degeneration in a Chinese cohort","volume":"488","author":"Dong","year":"2011","journal-title":"Neurosci Lett"},{"issue":"8","key":"10.1016\/j.ajo.2011.08.033_bib54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/IAE.0b013e3181cea676","article-title":"Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population","volume":"30","author":"Liu","year":"2010","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ophtha.2008.11.011","article-title":"Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy","volume":"116","author":"Kondo","year":"2009","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2011.08.033_bib56","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.ophtha.2010.02.003","article-title":"C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression","volume":"117","author":"Robman","year":"2010","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1350-9462(99)00009-9","article-title":"Oxidative damage and protection of the RPE","volume":"19","author":"Cai","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2011.08.033_bib58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12031-007-0044-1","article-title":"F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease","volume":"33","author":"Montine","year":"2007","journal-title":"J Mol Neurosci"},{"issue":"5","key":"10.1016\/j.ajo.2011.08.033_bib59","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","article-title":"Lipid peroxidation in aging brain and Alzheimer's disease","volume":"33","author":"Montine","year":"2002","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.ajo.2011.08.033_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2006.09.056","article-title":"Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration","volume":"143","author":"Moriarty-Craige","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411006751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939411006751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:04:55Z","timestamp":1757595895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939411006751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0002939411006751"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2011.08.033","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Biomarkers of Oxidative Stress and Genetic Variants in Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2011.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}